The discovery of potent USP2/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The discovery of potent USP2/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364

Published:2024-03 Issue: Volume:268 Page:116275
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Tian Yucheng,Liu Kang,Wu Dongdong,Wu Liuyi,Xu Qianqian,Wei Wei,Li Zhiyu,Du Qianming,Bian Jinlei^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference30 articles.

1. Synergistic chemotherapy for breast cancer and breast cancer brain metastases via paclitaxel-loaded oleanolic acid nanoparticles;You;Mol. Pharm.,2020

2. Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasis;Jin;Eur. J. Med. Chem.,2023

3. Selective estrogen receptor degraders (SERDs) for the treatment of breast cancer: an overview;Neha;Eur. J. Med. Chem.,2023

4. Discovery, optimization, and evaluation of selective CDK4/6 inhibitors for the treatment of breast cancer;Wei;J. Med. Chem.,2022

5. Targeting the estrogen receptor for the treatment of breast cancer: recent advances and challenges;Rohan;J. Med. Chem.,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases;Biomedicine & Pharmacotherapy;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP